Long-term Outcome Recruiting Phase 4 Trials for Dexmedetomidine (DB00633)

IndicationStatusPhase
DBCOND0081476 (Long-term Outcome)Recruiting4
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT03629483Dexmedetomidine Combined With Ropivacaine for Postoperative Continuous Femoral Nerve BlockPrevention
NCT03012971Dexmedetomidine Supplemented Analgesia and 2-Year Survival After Cancer SurgeryPrevention